Navigation Links
FASEB joins President Obama in urging Congress to sustain investments in research and innovation

Bethesda, MD The Federation of American Societies for Experimental Biology (FASEB) enthusiastically supports President Barack Obama's call to Congress to maintain key federal investments in research and development as outlined in his State of the Union address last night. "Once again we sincerely appreciate the President's emphasis on scientific innovation and his willingness to make funding for research a national priority. We should not sacrifice our commitment to the research that has dramatically improved the quality of life for Americans and people around the world," stated Judith S. Bond, PhD, FASEB President.

FASEB also praised the President's emphasis on increasing investments in science and innovation. President Obama said, "Now is not the time to gut these job-creating investments in science and innovation. Now is the time to reach a level of research and development not seen since the height of the Space Race." In addition, the President noted that the automatic spending cuts known as sequestration would devastate priorities like education, energy, and medical research. "We will continue our advocacy efforts to urge Congress to sustain federal funding for the National Institutes of Health, the National Science Foundation, and the other research agencies," said Dr. Bond. Scientists and researchers from around the country have already sent nearly 20,000 emails to Capitol Hill in response to e-action alerts issued by FASEB. "I urge everyone in the scientific community to contact their members of Congress today and forward the FASEB alert to their colleagues," added the FASEB President.


Contact: Lawrence Green
Federation of American Societies for Experimental Biology

Page: 1

Related biology news :

1. FASEB SRC announces conference registration open for: Melatonin Biology: Actions & Therapeutics
2. FASEB SRC announces conference: TGF-β Superfamily: Signaling in Development & Disease
3. FASEB SRC announces conference registration open for: Mobile DNA in Mammalian Genomes
4. FASEB SRC announces conference registration open for: NAD Metabolism & Signaling
5. FASEB SRC announces conference registration open for: Histone Deacetylases, Sirtuins, and Reversible Acetylation in Signaling and Disease
6. FASEB SRC announces conference registration open for: Genetic Recombination & Genome Rearrangements
7. FASEB SRC announces conference registration open for: Signal Transduction in the Immune System
8. FASEB SRC announces conference registration open for: Biology of Cilia and Flagella
9. FASEB SRC announces conference registration open for: Arf and Rab Family G Proteins
10. FASEB SRC announces conference: Glucose transport -- Gateway for Metabolic Systems Biology
11. FASEB SRC announces conference: Mitochondrial Assembly & Dynamics in Health, Disease & Aging
Post Your Comments:
(Date:10/4/2017)... , Oct. 4, 2017  GCE Solutions, a global clinical ... data and document anonymization solution on October 4, 2017. Shadow is ... field to comply with policy 0070 of the European Medicines Agency ... data. ... GCE Solutions ...
(Date:7/20/2017)... , July 20, 2017 Delta (NYSE: DAL ) ... any Delta aircraft at Reagan Washington National Airport (DCA). ... Delta launches biometrics to board ... Delta,s biometric boarding ... Club is now integrated into the boarding process to allow eligible ...
(Date:6/14/2017)... -- IBM (NYSE: IBM ) is introducing several innovative partner ... developing collaboration between startups and global businesses, taking place in ... event, nine startups will showcase the solutions they have built ... France is one of ... 30 percent increase in the number of startups created between ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. 11, ... Research, London (ICR) and University of ... SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma (MM), ... nine . The University of Leeds ... funded by Myeloma UK, and ICR will perform the testing ...
(Date:10/10/2017)... Angeles, CA (PRWEB) , ... ... ... Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, ... uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in ...
(Date:10/10/2017)... , ... October 10, 2017 , ... ... and business process optimization firm for the life sciences and healthcare industries, announces ... conference in San Francisco. , The presentation, “Automating GxP Validation for Agile Cloud ...
(Date:10/9/2017)... (PRWEB) , ... October 09, 2017 , ... ... a four-tiered line of medical marijuana products targeting the needs of consumers who ... packaging of Kindred takes place in Phoenix, Arizona. , As operators of two ...
Breaking Biology Technology: